Active, Not Recruiting
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)
NCT07266558
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
- Locations
-
- Accel Clinical Research Birmingham, Alabama, United States
- Cullman Clinical Trials Cullman, Alabama, United States
- AMR Clinical Mobile Mobile, Alabama, United States
- Velocity Clinical Research, Mobile Mobile, Alabama, United States